Higher VEGF expression in breast tumors was associated with advanced prognosticators including larger tumor size, high histologic grade, hormone receptor-negative status, HER2-overexpression, and lymph node metastasis [29–32]. The gene discussed is ERBB2; the disease is breast neoplasm.